论文部分内容阅读
目的:分析辛伐他汀在脑血栓治疗中的应用效果。方法:2013年1月至2014年1月,选取我院收治的80例脑血栓患者作为研究对象,随机分成对照组和观察组,对照组40例,实验组40例,对照组患者给予常规治疗和阿司匹林;实验组患者在对照组的基础之上给予辛伐他汀的治疗,对比两组患者的疗效。结果:两组患者的临床治疗有效率上,实验组的治疗效果明显优于对照组,P<0.05,具有统计学意义。结论:辛伐他汀对治疗脑血栓有明显的疗效,可以有效地延缓动脉的粥样硬化,降血脂,值得推广应用。
Objective: To analyze the effect of simvastatin on cerebral thrombosis. Methods: From January 2013 to January 2014, 80 patients with cerebral thrombosis treated in our hospital were enrolled and randomly divided into control group and observation group. The control group was 40 cases and the experimental group was 40 cases. The control group was given routine treatment And aspirin. Patients in the experimental group were given simvastatin on the basis of the control group, and the curative effect was compared between the two groups. Results: The clinical treatment efficiency of the two groups was significantly better than that of the control group (P <0.05), which was statistically significant. Conclusion: Simvastatin has obvious curative effect on treating cerebral thrombosis, which can effectively delay the atherosclerosis and lipid-lowering of arteries, which is worth popularizing and applying.